The company
Traws Pharma, Inc.
TRAW · Nasdaq
TRAW stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 30 weeks. It is 63.4% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 30
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $2.0M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 31 (+4)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Orbimed Advisors Llc10% owner | bought | 597,729at $1.67 | 16 Apr 2026filed 28 Apr 2026 |
| Orbimed Advisors Llc10% owner | bought | 597,729 | 16 Apr 2026filed 28 Apr 2026 |
| Orbimed Advisors Llc10% owner | bought | 597,729 | 16 Apr 2026filed 28 Apr 2026 |
| Orbimed Advisors Llc10% owner | bought | 1,793,187 | 16 Apr 2026filed 28 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| ORBIMED ADVISORS LLCadded · filed 14 Aug 2026 | 1,203,260$1.0M | +597,729+98.7% |
| Ally Bridge Group (NY) LLCnew · filed 14 Aug 2026 | 786,236$663K | +786,236 |
| ADAGE CAPITAL PARTNERS GP, L.L.C.unchanged · filed 14 Aug 2026 | 730,000$616K | 00.0% |
| ADAR1 Capital Management, LLCadded · filed 14 Aug 2026 | 597,729$504K | +443,631+287.9% |
| Lynx1 Capital Management LPadded · filed 12 Aug 2026 | 559,470$472K | +544,392+3610.5% |
| Ikarian Capital, LLCreduced · filed 14 Aug 2026 | 478,142$403K | -200,000−29.5% |
| SPHERA FUNDS MANAGEMENT LTD.new · filed 14 Aug 2026 | 398,486$336K | +398,486 |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 330,049$278K | +274,856+498.0% |
| JANE STREET GROUP, LLCadded · filed 14 Aug 2026 | 216,006$182K | +194,765+916.9% |
| Alyeska Investment Group, L.P.new · filed 14 Aug 2026 | 164,376$139K | +164,376 |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.